diagnostic quality images are the key
and those cannot be measured at an open house demo. It is not enough to put pictures on a screen, whether they can be moved or not.
the images have to be DIAGNOSTICALLY USEFUL The only way that can be demonstrated or measured is with clinical studies. IMGG has, for over a year, refused to conduct such studies and have feigned ignorance of such a requirement.
An image of a hand moving doesn't prove anything since the intended use of this device is in surgical applications where it is a mater of life and death, that what is imaged to be CUT is what is being CUT by the surgeon. That is no simple task, which is why this device is supposedly better than any other. That it hasn't been demonstrated suggests this was nothing more than a claim.
That is the only thing that matters--not whether "we" can get the stock price high enough so our "friends" can get out whole.
News 
Market Data 
Discover 
AI
